The contraceptive vaginal ring is a novel contraceptive method that offers unique advantages. Intravaginal delivery of both estrogen and progesterone allows continuous release of medication, resulting in lower systemic levels. The use of long-term combined hormonal contraception enables improved cycle control compared with progesterone-only methods. The indications and usage of the NuvaRing® are described along with the efficacy, tolerability, and safety. Overall, the contraceptive vaginal ring appears to be very effective, with a favorable side-effect profile, and is highly acceptable to most patients. © 2010 Wieder and Pattimakiel, publisher and licensee Dove Medical Press Ltd.
CITATION STYLE
Wieder, D. R., & Pattimakiel, L. (2010). Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (nuvaring®). International Journal of Women’s Health, 2(1), 401–409. https://doi.org/10.2147/IJWH.S6162
Mendeley helps you to discover research relevant for your work.